2013-11-13T11:02:31-06:00 2012-12-31 521392008 GELMAN ROSENBERG & FREEDMAN 4550 MONTGOMERY AVE SUITE 650N BETHESDA MD 208142930 990 2012-01-01 911157127 PROGRAM FOR APPROPRIATE TECHNOLOGY IN HEALTH (PATH) PROG 2062853500 2201 WESTLAKE AVENUE NO 200 SEATTLE WA 98121 OLIVIA POLIUS 2062853500 2013-11-13 1 3019519090 2012 2016-02-25 16:41:14Z PATH STEVE DAVIS 2201 WESTLAKE AVENUE NO 200 SEATTLE WA 98121 250492013 0 X WWW.PATH.ORG X 1981 WA SEE PART III, LINE 1. 11 11 646 0 0 0 240628741 171536869 79515 27292 3343515 2677407 385259 739627 244437030 174981195 74959310 70398415 0 0 82582493 90685304 0 0 1528457 99424526 113262887 256966329 274346606 -12529299 -99365411 612675555 507730565 66607920 59191414 546067635 448539151 X PATH IS AN INTERNATIONAL NONPROFIT ORGANIZATION THAT DRIVES TRANSFORMATIVE INNOVATION IN GLOBAL HEALTH. OUR MISSION IS TO IMPROVE THE HEALTH OF PEOPLE AROUND THE WORLD BY ADVANCING SUSTAINABLE TECHNOLOGIES, STRENGTHENING SYSTEMS, AND ENCOURAGING HEALTHY BEHAVIORS. 0 0 93084229 27964496 502 EMERGING AND EPIDEMIC DISEASES: EMERGING AND EPIDEMIC DISEASES, INCLUDING MALARIA, HIV/ AIDS, AND TUBERCULOSIS (TB), CLAIM LIVES AND UNDERMINE COMMUNITIES WORLDWIDE. DEVELOPING COUNTRIES, WHERE CHRONIC POVERTY AND WEAK HEALTH SYSTEMS CHALLENGE RESPONSES AND COMPOUND THE BURDEN OF ILLNESS, ARE PARTICULARLY HARD HIT. PATH WORKS WITH PUBLIC- AND PRIVATE-SECTOR PARTNERS, HEALTH ORGANIZATIONS, AND COMMUNITIES TO BREAK THIS CYCLE BY INCREASING PREVENTION, CONTROL, DIAGNOSIS, AND TREATMENT; STRENGTHENING HEALTH SYSTEMS; ADVANCING RELEVANT TECHNOLOGIES AND STRATEGIES; AND EMPOWERING CITIZENS TO ADOPT HEALTHY BEHAVIORS AND CONFRONT HARMFUL SOCIAL NORMS. IN 2012, ONE OF OUR KEY ACHIEVEMENTS WAS THE DEVELOPMENT OF A SEMISYNTHETIC FORM OF ARTEMISININ, THE KEY INGREDIENT IN TOP MALARIA TREATMENTS. OUR DRUG DEVELOPMENT PROGRAM, PATH DRUG SOLUTIONS, WORKED WITH PARTNERS TO DEVELOP AND MANUFACTURE THE DRUG, WHICH WILL SUPPLEMENT FLUCTUATING BOTANICAL SUPPLIES, STABILIZE THE MARKET, AND INCREASE THE AVAILABILITY OF LIFESAVING ANTIMALARIAL MEDICINES. AFTER SUCCESSFULLY COMPLETING PROCESS VALIDATION, WE PRODUCED SEVERAL TONS OF MATERIALS FOR TESTING BY POTENTIAL CUSTOMERS. PRODUCTION IS SET TO GROW IN 2013, AND WILL INCREASE FURTHER BY 2014.TO DECREASE MALARIA TRANSMISSION, PATH WORKS WITH NATIONAL PROGRAMS TO EXPAND COMPREHENSIVE TESTING AND TREATMENT, IMPROVE DATA COLLECTION, AND INCREASE SURVEILLANCE. THESE ACTIVITIES ARE PART OF A STRATEGY TO END TRANSMISSION ALTOGETHER, WITH THE ULTIMATE GOAL OF ELIMINATING MALARIA.FOR EXAMPLE, OUR MALARIACARE PROJECT BEGAN A WIDE-REACHING EFFORT TO IMPROVE DIAGNOSTIC TESTING, TREATMENT, AND LABORATORY SERVICES THROUGHOUT AFRICA, WITH THE GOAL OF CUTTING THE BURDEN OF MALARIA BY HALF AMONG A POPULATION OF 450 MILLION. IN ZAMBIA, WE HELPED TRAIN MORE THAN 1,100 WORKERS TO IDENTIFY, REPORT, TREAT, AND MONITOR INFECTIONS. IN ETHIOPIA, WE PARTNERED WITH LEADERS TO CREATE MALARIA ELIMINATION LEARNING DISTRICTS. AND IN SENEGAL, A NEW EFFORT IS HARNESSING THE POWER OF SMARTPHONES TO REPORT DATA DURING COMMUNITY-WIDE TEST-AND-TREAT CAMPAIGNS. WE ALSO SUPPORTED MALARIA ELIMINATION BY IDENTIFYING AND ANALYZING THE UNIQUE TECHNICAL REQUIREMENTS AND MARKET NEEDS OF DIAGNOSTIC TECHNOLOGIES THAT CAN DETECT REMAINING RESERVOIRS OF INFECTION AMONG PEOPLE WHO MAY NOT SHOW SYMPTOMS. THIS WORK WILL PROVIDE COUNTRIES, DONORS, AND DEVELOPERS WITH EVIDENCE ABOUT COST-EFFECTIVE DIAGNOSTIC TOOLS AND TACTICS AS THEY FOCUS ON ELIMINATION STRATEGIES.TO REDUCE THE BURDEN OF HIV, PATH FOCUSED ON STRENGTHENING DIAGNOSIS, CARE, AND TREATMENT SERVICES; STEPPING UP PREVENTION EFFORTS, INCLUDING PREVENTING MOTHER-TO-CHILD TRANSMISSION; AND BUILDING THE FOUNDATIONS LOCAL AND NATIONAL HEALTH SYSTEMS NEED TO COMBAT THE DISEASE. OUR 2012 EFFORTS INCLUDED PROVIC, A PROJECT IN THE DEMOCRATIC REPUBLIC OF CONGO THAT DREW ON THE RESOURCES OF NEARLY 100 LOCAL PARTNERS TO REACH AN ESTIMATED 1.4 MILLION PEOPLE WITH HIV PREVENTION MESSAGES, 430,000 PEOPLE WITH COUNSELING AND TESTING, AND 80,000 WOMEN WITH SERVICES TO PREVENT MOTHER-TO-CHILD TRANSMISSION OF HIV. PATH ALSO LAUNCHED A PUBLIC-PRIVATE PARTNERSHIP WITH TENKE FUNGURUME MINING, THE COUNTRY'S LARGEST FOREIGN INVESTOR, ALONG THE MINING AND TRUCKING CORRIDORS OF THE SOUTHERN PART OF THE COUNTRY. IN THESE HIV "HOTSPOTS," WE WORKED WITH PARTNERS AT THE COMMUNITY AND CLINIC LEVELS TO ADDRESS HIV AMONG HIGH-RISK POPULATIONS AND PREVENT TRANSMISSION FROM MOTHERS TO THEIR CHILDREN.IN WESTERN KENYA, APHIAPLUS, A COMPREHENSIVE PORTFOLIO OF COMMUNITY-BASED PROGRAMS HAS IMPROVED SERVICES, STRENGTHENED COMMUNITIES, AND CONFRONTED THE SOCIAL AND ECONOMIC CAUSES OF POOR HEALTH. THE PROJECT HAS ALLOWED MORE THAN 500,000 PEOPLE TO GET HIV TESTING AND COUNSELING AND MORE THAN 53,000 TO GET TREATMENT; REACHED 6.6 MILLION KENYAN YOUTH WITH HIV PREVENTION INFORMATION; INCREASED THE NUMBER OF BIRTHS ASSISTED BY SKILLED BIRTH ATTENDANTS TO NEARLY 61,000; AND PROVIDED SCHOOL FEES, CARE, AND DAY-TO-DAY NECESSITIES FOR MORE THAN 170,000 ORPHANS AND VULNERABLE CHILDREN.PATH ALSO WORKS WITH DIVERSE PARTNERS TO COMBAT TB, INCLUDING DRUG-RESISTANT TB, BY IMPROVING DIAGNOSIS, TREATMENT, AND CARE AND INTEGRATING TB INTO HEALTH SERVICES FOR HIV, CHILD HEALTH, DIABETES, AND OTHER CONDITIONS. IN TANZANIA AND ZANZIBAR, FOR EXAMPLE, WE SUPPORTED THE MINISTRIES OF HEALTH IN DEVELOPING AND IMPLEMENTING AN INTEGRATED STRATEGY TO PROVIDE SERVICES TO PATIENTS WITH TB AND HIV THAT IS NOW USED IN MORE THAN 1,000 HEALTH FACILITIES. HEALTH STAFF HAVE IDENTIFIED MORE THAN 23,000 PATIENTS WITH TB, WITH 90% TESTED FOR HIV AND INFORMED OF THEIR RESULTS. 85483955 30775114 3447 VACCINES AND IMMUNIZATION:VACCINES OFFER RELIABLE, LOW-COST PROTECTION AGAINST LIFE-THREATENING DISEASE, MAKING THEM ONE OF THE MOST EFFECTIVE HEALTH INTERVENTIONS OF ALL TIME. IN LOW-RESOURCE COUNTRIES, WHERE HEALTH SERVICES ARE OFTEN TOO REMOTE OR EXPENSIVE TO SAVE CHILDREN'S LIVES ONCE THEY ARE SICK, VACCINES MAY BE THEIR BEST CHANCE FOR SURVIVAL.PATH IS WORKING TO IMPROVE ACCESS TO VACCINES IN LOW-RESOURCE COUNTRIES AROUND THE WORLD. OUR PROJECTS INCREASE AVAILABILITY, ACCELERATE RESEARCH AND DEVELOPMENT, AND STRENGTHEN SUPPLY CHAIN SYSTEMS. THROUGH THIS WORK, WE ARE MAKING PROGRESS AGAINST POTENTIALLY DEADLY HEALTH THREATS SUCH AS CERVICAL CANCER, DIARRHEAL DISEASE, JAPANESE ENCEPHALITIS, MALARIA, MENINGITIS, PANDEMIC INFLUENZA, AND PNEUMOCOCCAL DISEASE. IN 2012, WE USED INNOVATIVE APPROACHES TO BRING VACCINES TO MORE COMMUNITIES, ADVANCED NEW VACCINE CANDIDATES, STRENGTHENED VACCINE SUPPLY CHAINS AND SYSTEMS, AND SUCCESSFULLY ADVOCATED TO PROTECT VACCINES FOR MILLIONS OF CHILDREN.FOR EXAMPLE, PATH SUPPORTED 13 ASIAN COUNTRIES TO SAFELY AND EFFECTIVELY ADOPT A VACCINE AGAINST JAPANESE ENCEPHALITIS, THE LEADING CAUSE OF DISABILITY IN ASIA.IN AFRICA, THE LIFESAVING MENAFRIVAC VACCINE, DEVELOPED THROUGH A PARTNERSHIP BETWEEN PATH AND THE WORLD HEALTH ORGANIZATION (WHO) IN COLLABORATION WITH SERUM INSTITUTE OF INDIA LTD., CONTINUED TO SAVE LIVES. THIS YEAR, 48 MILLION PEOPLE WERE VACCINATED, PART OF THE 100 MILLION PEOPLE ACROSS 10 AFRICAN COUNTRIES WHO HAVE RECEIVED THE VACCINATION SINCE ITS INTRODUCTION. THE VACCINE ALSO BECAME THE FIRST IN AFRICA APPROVED FOR TRANSPORT AND STORAGE OUTSIDE THE TRADITIONAL COLD CHAIN, HELPING HEALTH WORKERS REACH PEOPLE IN REMOTE AREAS.TOGETHER WITH PARTNERS, PATH ALSO ADVANCED THE PROMISING RTS, A MALARIA VACCINE CANDIDATE, WHICH WAS SHOWN TO REDUCE MALARIA EPISODES BY ONE-THIRD AMONG AFRICAN INFANTS(ABOUT 270 CASES AVERTED PER 1,000 INFANTS)AND BY ONE-HALF AMONG TODDLERS (ABOUT 750 CASES AVERTED PER 1,000 TODDLERS) OVER THE FIRST YEAR OF FOLLOW-UP.IN CHINA, WE CREATED A PROJECT DEVELOPMENT PARTNERSHIP WITH PUBLIC- AND PRIVATE-SECTOR PARTNERS TO OBTAIN WHO PREQUALIFICATION OF VACCINES FOR GLOBAL PROCUREMENT PROGRAMS.PROJECT OPTIMIZE, A PATH-WHO COLLABORATION, MADE NEW STRIDES TOWARD STRENGTHENING THE SUPPLY CHAINS AND SYSTEMS THAT MANAGE, STORE, AND DELIVER VACCINES TO THOSE WHO NEED THEM. KEY ACHIEVEMENTS INCLUDED A DIGITAL IMMUNIZATION REGISTRY IN VIETNAM TO MONITOR CHILDREN DUE FOR VACCINATIONS THAT REDUCED THE TIME HEALTH WORKERS SPENT RECORDING DATA BY HAND, PROVIDED A WAY TO REMIND MOTHERS OF UPCOMING VACCINATIONS, AND RESULTED IN A MARKED INCREASE IN ON-TIME VACCINATION RATES. IN SOUTH SUDAN, OUR TESTS OF A CLOUD-BASED SYSTEM TO MANAGE VACCINE STOCKS USING A CELL PHONE PROVIDED A NEW WAY TO TRACK REAL-TIME SUPPLY AND DEMAND. THE TEAM EXPLORED THE USE OF BATTERY-FREE VACCINE REFRIGERATORS AND HYBRID SOLAR-ELECTRIC SYSTEMS TO MAINTAIN THE COLD CHAIN IN RURAL AREAS, AND ELECTRIC VEHICLES AND SPECIALLY EQUIPPED TRUCKS TO STREAMLINE DELIVERY. IN ADDITION, RECOGNIZING THAT VACCINE INTRODUCTION IS ACCELERATING WORLDWIDE, WE CREATED AN INTERACTIVE EXHIBIT TO INTRODUCE LEADERS, LAWMAKERS, AND STAKEHOLDERS TO VACCINE SUPPLY AND LOGISTICS SYSTEMS AND SPARK COMMITMENT AND INNOVATION TO SOLVE CHALLENGES.PATH'S ADVOCACY AND COMMUNICATIONS EFFORTS ALSO ACHIEVED GAINS IN 2012. AS THE LEADER OF THE VACCINE IMPLEMENTATION TECHNICAL ASSISTANCE CONSORTIUM (VITAC, FORMERLY AVI TAC), WE ASSISTED THE GLOBAL ALLIANCE FOR VACCINES AND IMMUNIZATION (GAVI) WITH COMMUNICATIONS AND ADVOCACY SUPPORT, CREATED A STRATEGIC FORECASTING TOOL TO PREDICT VACCINE SUPPLY AND DEMAND, AND DEMONSTRATED THE IMPACT OF ROTAVIRUS AND PNEUMOCOCCAL VACCINES. GHANA AND TANZANIA SIMULTANEOUSLY INTRODUCED BOTH VACCINES INTO THEIR NATIONAL IMMUNIZATION PROGRAMS, AND PATH PROVIDED DOCUMENTATION, ADVOCACY, AND GLOBAL MEDIA RELATIONS SUPPORT FOR THIS BOLD EFFORT. IN MALAWI, PATH OUTREACH AND ADVOCACY SUPPORTED THE NATIONWIDE INTRODUCTION OF A ROTAVIRUS VACCINE.IN ADDITION, PATH ADVOCACY HELPED TO SAFEGUARD ACCESS TO CHILDHOOD VACCINES IN A GLOBAL TREATY LIMITING MERCURY IN THE ENVIRONMENT. TOGETHER WITH PARTNERS, WE INFORMED AND INFLUENCED KEY DECISION-MAKERS, WHO AGREED TO EXCLUDE VACCINES CONTAINING THE PRESERVATIVE THIOMERSAL FROM REGULATION. 23846345 4290981 17533 HEALTH TECHNOLOGIES:PATH DEVELOPS AND INTRODUCES APPROPRIATE, AFFORDABLE TECHNOLOGIES TO ADDRESS URGENT HEALTH CHALLENGES, PARTICULARLY IN LOW-RESOURCE SETTINGS. OUR LOW-COST, EVIDENCE-BASED PRODUCTS, DESIGNED WITH INPUT FROM USERS AND RECIPIENTS, ARE TRANSFORMING HEALTH WORLDWIDE. WE ALSO IMPROVE THE TECHNOLOGY AND INFORMATION SYSTEMS THAT HELP HEALTH WORKERS MONITOR AND PROVIDE HEALTH SERVICES.PATH'S DIAGNOSTICS WORK INCLUDES DEVELOPING OR ADVANCING AFFORDABLE TESTS FOR THE RAPID DETECTION OF MALARIA, MULTIDRUG-RESISTANT TB, NEGLECTED TROPICAL DISEASES, SEXUALLY TRANSMITTED INFECTIONS, AND OTHER HEALTH CONCERNS. IN 2012, THE CAREHPV TEST, WHICH DETECTS THE CAUSE OF CERVICAL CANCER, WENT ON SALE IN CHINA, AND IT WILL SOON BE AVAILABLE IN INDIA AND OTHER COUNTRIES. THE TEST WAS DEVELOPED BY PATH AND QIAGEN, THE TRADEMARK HOLDER, FOR USE IN EVEN BASIC HEALTH CLINICS, AND CAN BE USED ON SAMPLES SELF-COLLECTED BY WOMEN.IN CAMBODIA, INDIA, MEXICO, AND TANZANIA, PATH EVALUATED NEW TECHNOLOGIES TO IDENTIFY PEOPLE LIVING WITH DIABETES. THIS INCLUDED A RAPID DIAGNOSTIC TEST TO SCREEN PREGNANT WOMEN FOR GESTATIONAL DIABETES.IN ADDITION, WE ADVANCED A LOW-COST, POINT-OF-CARE DIAGNOSTIC TEST FOR ONCHOCERCIASIS (RIVER BLINDNESS) TO AID GLOBAL MONITORING AND ELIMINATION EFFORTS, AND IDENTIFIED A MANUFACTURING PARTNER TO CREATE AND DISTRIBUTE THE PRODUCT. PATH ALSO ADVANCED NEW TREATMENT OPTIONS FOR NEGLECTED TROPICAL DISEASES, INCLUDING A NEW ANTIBIOTIC, CALLED THE PAROMOMYCIN INTRAMUSCULAR INJECTION (PMIM), DEVELOPED BY OUR DRUG DEVELOPMENT PROGRAM, PATH DRUG SOLUTIONS, TO TREAT VISCERAL LEISHMANIASIS. THE INJECTION WAS REGISTERED BY THE GOVERNMENT OF NEPAL, AND WE COMPLETED A PHASE 3(B) CLINICAL TRIAL IN BANGLADESH, SUPPORTING EFFORTS TO REGISTER PMIM THERE AND CONTRIBUTING TO A NATIONAL ELIMINATION STRATEGY.IN ADDITION, WE CONTINUED WORK TO DEVELOP AN ELECTRICITY-FREE NON-INSTRUMENTED NUCLEIC ACID AMPLIFICATION DEVICE. DESIGNED TO DETECT DISEASES, SUCH AS ACUTE AND INFANT HIV, THAT ARE OTHERWISE CHALLENGING TO DIAGNOSE IN LOW-RESOURCE SETTINGS, THIS DEVICE WILL SPEED DIAGNOSIS AND TREATMENT.IN 2012, WE ALSO CONTINUED OUR WORK TO IMPROVE FAMILIES ACCESS TO SAFE WATER. FOR EXAMPLE, WE DEVELOPED DESIGN GUIDELINES NOW BEING USED BY THREE CHINESE MANUFACTURERS SELLING LOW-COST HOUSEHOLD WATER FILTERS. WE USED CREATIVE, MARKET-BASED STRATEGIES, INCLUDING MICROFINANCE LOANS AND COMMERCIAL PARTNERSHIPS, TO PROVIDE THOUSANDS OF LOW-INCOME CONSUMERS IN ASIA AND AFRICA WITH ACCESS TO SAFE WATER. OUR CONTINUED FOCUS ON EFFECTIVE, AFFORDABLE FAMILY PLANNING OPTIONS INCLUDED WORK TO DEVELOP ROBUST AND SUSTAINABLE MARKETS FOR THE EFFECTIVE, EASY-TO-USE SILCS DIAPHRAGM AND TO ADVANCE THE WOMAN'S CONDOM. PATH DESIGNED BOTH TECHNOLOGIES TO BE ACCEPTABLE, AFFORDABLE, AND ACCESSIBLE FOR USERS WORLDWIDE.FINALLY, OUR HEALTH MANAGEMENT INFORMATION SYSTEMS GROUP CONTINUED TO RESEARCH, DEVELOP, AND ADAPT INFORMATION AND COMMUNICATION TECHNOLOGY PRODUCTS (E.G., COMPUTER SOFTWARE) TO HELP HEALTH WORKERS AND LEADERS MONITOR AND PROVIDE SERVICES AT THE LOCAL AND NATIONAL LEVEL. FOR EXAMPLE, WE HELPED HEALTH WORKERS FROM KENYA, RWANDA, SENEGAL, AND VIETNAM IDENTIFY A SET OF BUSINESS PROCESSES AND USER REQUIREMENTS COMMON TO THEIR NATIONAL SUPPLY CHAIN SYSTEMS, INFORMATION THAT MAY BE USED TO IMPROVE SUPPLY CHAINS AND LOGISTICS INFORMATION MANAGEMENT. 15406708 2240211 MATERNAL AND CHILD HEALTH:PATH IMPROVES THE HEALTH OF WOMEN AND CHILDREN THROUGH EVIDENCE-BASED APPROACHES THAT ADDRESS THE LEADING CAUSES OF MATERNAL AND CHILD DEATH IN LOW-INCOME COUNTRIES. IN 2012, OUR PROJECTS FOCUSED ON INNOVATIVE INTERVENTIONS AND TECHNOLOGIES TO IMPROVE SAFE BIRTH AND NEWBORN CARE, BOLSTER NUTRITION, CONTROL AND PREVENT PNEUMONIA AND DIARRHEAL DISEASE, AND ADVANCE PROMISING VACCINES. ESSENTIAL MATERNAL HEALTH MEDICINES CAN PREVENT OR TREAT THE LEADING CAUSES OF MATERNAL DEATHS. IN 2012, PATH DEVELOPED A TARGETED POLICY AGENDA FOR GLOBAL AND NATIONAL DECISION-MAKERS TO INCREASE WOMEN'S ACCESS TO THESE MEDICINES.IN ADDITION, THROUGH A UNIQUE PUBLIC-PRIVATE COLLABORATION WITH THE PHARMACEUTICAL COMPANY MERCK, WE IDENTIFIED AND ASSESSED NEARLY 40 TOOLS AND TECHNOLOGIES WITH THE POTENTIAL TO PREVENT DEATHS FROM COMPLICATIONS DURING PREGNANCY AND CHILDBIRTH. FINDINGS AND RECOMMENDATIONS HAVE BEEN MADE AVAILABLE TO DONORS, NATIONAL GOVERNMENTS, BUSINESSES, AND OTHER GROUPS, AND MAY HELP THEM MAKE SMART INVESTMENTS IN MATERNAL HEALTH PRODUCTS AND RESEARCH. TO IMPROVE NUTRITION, WE WORKED WITH THE UNIVERSITY OF WASHINGTON AND THE HUMAN MILK BANKING ASSOCIATION OF SOUTH AFRICA TO DEVELOP A LOW-COST SYSTEM THAT USES MOBILE PHONES TO MANAGE PASTEURIZATION OF DONATED BREAST MILK, AN ESSENTIAL SOURCE OF NUTRITION FOR INFANTS WHEN THEIR MOTHERS' MILK IS UNAVAILABLE.WE ALSO HELPED DEVELOP INNOVATIVE DISTRIBUTION MODELS TO INCREASE ACCESS TO RICE FORTIFIED WITH VITAMINS AND MINERALS USING THE ULTRA RICE FORTIFICATION TECHNOLOGY, ADVANCED BY PATH AND TRADEMARKED BY BON DENTE INTERNATIONAL, INC. FORTIFIED GRAINS ARE BEING INTEGRATED INTO LARGE-SCALE FOOD ASSISTANCE PROGRAMS IN BURUNDI AND CAMBODIA, COMMERCIAL RETAIL CHANNELS IN BRAZIL, AND SMALL-SCALE DISTRIBUTION CHANNELS IN VIETNAM. IN INDIA, WE HELPED ESTABLISH HIGH-QUALITY MANUFACTURING OF FORTIFIED GRAINS FOR A WORLD FOOD PROGRAMME PILOT PROJECT THAT WILL REACH 98,000 CHILDREN IN 2013.IN ADDITION, WE RENEWED OUR COMMITMENT TO COMBATING DIARRHEAL DISEASE AND PNEUMONIA, THE LEADING CAUSES OF CHILD DEATH WORLDWIDE. IN CAMBODIA, CONVINCING RESULTS FROM AN INTEGRATED APPROACH TO TREAT DIARRHEAL DISEASE AND PNEUMONIA LED TO ACCELERATED NATIONAL SCALE-UP, WITH PLANS TO REACH MORE THAN 1.6 MILLION CHILDREN BY 2014. IN ONE RURAL DISTRICT, CASES DROPPED DRAMATICALLY AFTER WE TRAINED HEALTH WORKERS AND PARENTS TO RECOGNIZE AND TREAT BOTH THREATS. OUR VACCINE DEVELOPMENT PROGRAM WORKED WITH AN INDIAN BIOTECHNOLOGY GROUP TO CONDUCT A PHASE 3 EFFICACY TRIAL OF A NEW VACCINE AGAINST ROTAVIRUS, ONE OF THE LEADING CAUSES OF SEVERE AND LIFE-THREATENING DIARRHEA AMONG CHILDREN. AND OUR PHASE 1 TRIAL OF A WHOLE-CELL VACCINE CANDIDATE DEVELOPED WITH PARTNERS AGAINST THE MOST COMMON CAUSE OF SEVERE PNEUMONIA YIELDED PROMISING RESULTS THAT SUPPORT CONTINUING CLINICAL DEVELOPMENT AND RESEARCH.IN KENYA, FAMILIES HAVE NEW, OVER-THE-COUNTER ACCESS TO ZINC, WHICH CAN CUT THE DURATION AND SEVERITY OF DIARRHEA. WE ARE WORKING WITH PROVINCIAL AND DISTRICT LEADERS TO ENSURE THIS NATIONAL POLICY CHANGE TRANSLATES INTO BROADER COMMUNITY ACCESS AND FEWER DEATHS.ADDITIONALLY, OUR INVESTIGATIONAL NEW DRUG TO TREAT ACUTE SECRETORY DIARRHEA IS SET TO PROCEED INTO THE NEXT ROUND OF STUDIES FOLLOWING THE SUCCESSFUL COMPLETION OF TWO PHASE 1 CLINICAL STUDIES IN THE UNITED STATES. THE TREATMENT COULD BECOME THE FIRST SYNTHETIC DRUG OF ITS KIND TO REDUCE FLUID LOSS, SHORTENING THE DURATION AND SEVERITY OF SYMPTOMS. 11683815 3460015 4123 REPRODUCTIVE HEALTH:PATH WORKS TO IMPROVE REPRODUCTIVE HEALTH BY STRENGTHENING ACCESS TO FAMILY PLANNING, IMPROVING SCREENING AND TREATMENT FOR CERVICAL AND BREAST CANCERS, PREVENTING SEXUALLY TRANSMITTED INFECTIONS, ADVOCATING FOR SERVICES AND SUPPLIES, INTRODUCING CONTRACEPTIVE TECHNOLOGIES, AND ENCOURAGING HEALTHY BEHAVIORS. KEY EFFORTS TO INCREASE CONTRACEPTIVE CHOICE AND ACCESS IN 2012 INCLUDED A PROJECT PAVING THE WAY FOR A NEW PACKAGING AND PRESENTATION OF A POPULAR INJECTABLE CONTRACEPTIVE. THE PRODUCT IS ADAPTED FOR DELIVERY IN THE UNIJECT INJECTION SYSTEM, DEVELOPED BY PATH AND TRADEMARKED BY BD. THE MEDICATION IS CONTAINED IN A PREFILLED PLASTIC BUBBLE FOR EASY DELIVERY, POTENTIALLY EXPANDING THE CADRE OF HEALTH WORKERS WHO CAN PROVIDE INJECTIONS. PATH HELPED LEAD RESEARCH IN AFRICA AND COORDINATED PILOT INTRODUCTION PLANNING AMONG GLOBAL AND COUNTRY PARTNERS. THE PRODUCT MAY PROVIDE NEW OPTIONS TO THE ESTIMATED 215 MILLION WOMEN WHO WANT TO PREVENT PREGNANCY BUT DO NOT USE OR HAVE ACCESS TO MODERN FAMILY PLANNING METHODS.PATH ALSO SERVED AS THE SECRETARIAT FOR THE REPRODUCTIVE HEALTH SUPPLIES COALITION, A GLOBAL PARTNERSHIP OF PUBLIC, PRIVATE, AND NONGOVERNMENTAL ORGANIZATIONS WORKING TO EXPAND ACCESS TO SUPPLIES, SERVICES, AND OPTIONS FOR PREVENTING UNINTENDED PREGNANCIES AND SEXUALLY TRANSMITTED INFECTIONS.AS PART OF ONGOING WORK TO ADDRESS THE GROWING BURDEN OF WOMEN'S CANCERS IN DEVELOPING COUNTRIES, WE PILOTED A COMMUNITY BREAST HEALTH PROJECT IN PERU THAT SCREENED MORE THAN 5,800 WOMEN FOR BREAST CANCER AND TRAINED DOZENS OF HEALTH PROVIDERS. A PLANNED EXPANSION TO ADDITIONAL AREAS IN 2013 WILL BRING THIS SERVICE TO EVEN MORE WOMEN.IN ADDITION, PATH'S EXPERIENCE INTRODUCING A VACCINE TO PREVENT HUMAN PAPILLOMAVIRUS (HPV), THE CAUSE OF CERVICAL CANCER, IN FOUR COUNTRIES LED TO THE DEVELOPMENT OF A SET OF PLANNING TOOLS THAT HAVE NOW BEEN USED BY GOVERNMENTS IN AFRICA, ASIA, AND LATIN AMERICA TO PREVENT FUTURE DEATHS FROM CERVICAL CANCER. 4251880 1667598 1687 CROSS-PROGRAM IMPACT INITIATIVES:PATH'S BROAD BASE OF EXPERTISE, EXPERIENCE, AND CAPACITY SPANS PROGRAMS AND STAFF IN MORE THAN 70 COUNTRIES. IN 2012, WE BEGAN A FORMAL STRATEGY TO INTEGRATE, COORDINATE, AND LEVERAGE THESE RESOURCES TO MAXIMIZE OUR IMPACT. WE BEGAN BY DEVELOPING CROSS-PROGRAM INITIATIVES RELATED TO PRIORITY HEALTH AREAS, INCLUDING MATERNAL AND NEONATAL HEALTH TECHNOLOGIES, DIARRHEAL DISEASE, AND PNEUMONIA. FUTURE PRIORITY HEALTH AREAS WILL INCLUDE MALARIA AND FAMILY PLANNING. 31342403 7367824 5810 233756932 1 1 0 1 0 0 0 0 0 1 1 0 0 0 0 0 0 1 0 1 1 1 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 1 0 0 0 0 1 1 1 0 0 1 X 218 0 1 646 1 0 1 BE CB CH CG ET FR GH IN IV KE NU PE SG SF TZ TH UG UP VM ZA MI 0 0 0 0 0 0 0 0 X 11 11 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 0 AZ CA CT FL IL MA MD NJ NY NC OH OR PA TX VA VT WA X X X OLIVIA POLIUS CHIEF FINANCIAL OFFICER 2062853500 2201 WESTLAKE AVE SUITE 200 SEATTLE WA 98121 MOLLY JOEL COYE 2.00 0.00 X X 0 0 0 VINCENT MCGEE 2.00 0.00 X X 0 0 0 DEAN ALLEN 2.00 0.00 X X 0 0 0 JAY SATIA 2.00 0.00 X X 0 0 0 ALEX CHIKA EZEH 2.00 0.00 X 0 0 0 EIVOR HALKJAER 2.00 0.00 X 0 0 0 GEORGE GOTSADZE 2.00 0.00 X 0 0 0 KEVIN REILLY 2.00 0.00 X 0 0 0 PHYLLIS CAMPBELL 2.00 0.00 X 0 0 0 SUPAMIT CHUNSUTTIWAT 2.00 0.00 X 0 0 0 WOODROW MYERS 2.00 0.00 X 0 0 0 CHRISTOPHER J ELIAS 36.00 4.00 X 223504 0 12905 STEVEN B DAVIS 36.00 4.00 X 215600 0 19353 ERIC G WALKER 36.00 4.00 X 252022 0 37003 AYORINDE ARNOLD AJAYI 40.00 0.00 X 260390 0 35796 CARLOS CLINTON CAMPBELL 40.00 0.00 X 199238 0 21797 CATHARINE HOWARD TAYLOR 40.00 0.00 X 204790 0 32180 DANIEL LASTER 37.00 3.00 X 215725 0 34457 DAVID C KASLOW 40.00 0.00 X 267606 0 26959 ERIC A ARNOLD 40.00 0.00 X 201899 0 34636 JACQUELINE D SHERRIS 37.00 3.00 X 260690 0 30493 JANE E HUTCHINGS 40.00 0.00 X 188006 0 32426 JOAN LITTLEFIELD 40.00 0.00 X 201776 0 22644 JOHN W BOSLEGO 40.00 0.00 X 330915 0 38973 JULIE M PULERWITZ 40.00 0.00 X 177897 0 30009 KATHLEEN M NEUZIL 40.00 0.00 X 221576 0 33469 KATHRYN A O'DRISCOLL 40.00 0.00 X 197574 0 29643 MARLOW KEE 36.00 4.00 X 203571 0 33892 MICHAEL J FREE 40.00 0.00 X 217699 0 36451 MICHELLE FOLSOM 40.00 0.00 X 171441 0 28104 RACHEL WILSON 40.00 0.00 X 176461 0 30427 RAMONA ANNE BYRKIT 40.00 0.00 X 219723 0 25034 RIKKA E TRANGSRUD 40.00 0.00 X 226667 0 27557 SARAH C TEMPLE 40.00 0.00 X 211095 0 24001 ASHLEY BIRKETT 40.00 0.00 X 232766 0 36184 DUNCAN OWENS EARLE 40.00 0.00 X 257329 0 33389 JEAN A NTUMBA BIDUAYA 40.00 0.00 X 239389 0 18139 JOHN SKIBIAK 40.00 0.00 X 344504 0 31676 TRAD M HATTON 40.00 0.00 X 231603 0 22803 6351456 0 820400 177 0 1 0 SLALOM LLC 821 2ND AVE STE 1900 SEATTLE WA 98124 GENERAL CONTRACTOR 1206709 WIDENET CONSULTING GROUP 11400 SE 6TH ST BELLEVUE WA 98004 GENERAL CONTRACTOR 671283 NORTHERN TRUST 50 S LASALLE ST CHICAGO IL 60675 ASSET MANAGEMENT 563300 COMMERICIAL OFFICE INTERIORS 2601 4TH AVE STE 700 SEATTLE WA 98121 GENERAL CONTRACTOR 470091 CLARK NUBER & CO 10900 NE 4TH STREET 1700 BELLEVUE WA 98004 ACCOUNTING SERVICES 266992 13 17915569 117500057 36121243 197437 171536869 HONORARIUM 900099 23285 23285 SALES 900099 4007 4007 27292 2286568 2286568 8885 8885 73961000 1940657 73416794 2094024 544206 -153367 390839 390839 GAIN-FOREIGN EXCH. 900099 379889 379889 REIMBURSEMENTS 900099 271965 271965 OTHER 900099 78888 78888 730742 174981195 27292 0 3417034 29604090 29604090 40794325 40794325 6103550 3993078 2102861 7611 64128607 38409258 25066685 652664 6124903 6124903 8740082 824534 7915548 5588162 385915 5202247 544901 180200 364701 427015 30927 396088 115999 24000 91999 421309 421309 10973529 6718913 4192049 62567 251243 200277 49041 1925 5885767 4607107 1231586 47074 897714 317336 538776 41602 71279 71279 9376412 1251716 8124696 20717871 18408831 2300980 8060 9259925 8675300 475997 108628 101664 101664 2884236 179178 2705058 486748 182165 304583 SUBCONTRACTS 40311864 39900585 411279 EQUIP RENT & MAINT 4503634 3178422 1310396 14816 FACILITIES ALLOC 0 9063437 -9299229 235792 LEAVE & BENS ALLOC 0 21468156 -21812606 344450 6031777 5287903 740606 3268 274346606 233756932 39061217 1528457 7282495 5456357 3303751 7755742 336128128 267202359 9125399 7835110 2606825 2621049 32986562 12627304 22080136 20359258 231566492 196097539 582329 403151 612675555 507730565 60627756 53959115 5980164 5232299 66607920 59191414 X 17628634 20660464 525069348 424503642 3369653 3375045 546067635 448539151 612675555 507730565 -99365411 1836927 0 X 0 1 X 1 1 1 X 270187073 257511086 152434405 240628741 171536869 1092298174 270187073 257511086 152434405 240628741 171536869 1092298174 404214642 688083532 9272569 5825631 4380066 2797154 2295453 24570873 483060 524296 1557958 502596 730742 3798652 1120667699 316422 0.61400 0.55080 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 193545 193545 274112686 274306231 1000000 250000 0 0 1000000 1000000 1000000 1000000 4000000 6000000 195195 219409 197270 193545 805419 250000 250000 250000 250000 1000000 1500000 4137 6398 10535 6868767 5392 932627 7806786 6671532 2700 194535 6868767 5943911 1790 725831 6671532 4752059 2039 1189813 5943911 6474476 21290 -1591603 152104 4752059 0.57000 0.43000 0 0 19846547 4896944 14949603 9674165 6667014 3007151 3465850 1063346 2402504 20359258 DESCRIPTION OF INTENDED USE OF ENDOWMENT FUNDS: PART V, LINE 4: PATH UTILIZES THE INVESTED INTEREST EARNINGS FROM THE ENDOWMENT AS AN IMPORTANT FUNDING SOURCE TO FUND NEW OPPORTUNITIES TO EXPAND ITS REACH AND IMPACT AS AN ORGANIZATION IN THE FIELD OF GLOBAL HEALTH, IN ACCORDANCE WITH PATH'S ENDOWMENT SPENDING POLICY. 1 CENTRAL AMERICA AND THE CARIBBEAN 1 1 MANAGEMENT & GENERAL MANAGEMENT & GENERAL 949 CENTRAL AMERICA AND THE CARIBBEAN 0 0 PROGRAM SERVICES REPRODUCTIVE HEALTH 368664 CENTRAL AMERICA AND THE CARIBBEAN 0 0 PROGRAM SERVICES EMERGING AND EPIDEMIC DISEASES 218969 CENTRAL AMERICA AND THE CARIBBEAN 0 0 PROGRAM SERVICES HEALTH TECHOLOGIES 85287 CENTRAL AMERICA AND THE CARIBBEAN 0 0 PROGRAM SERVICES VACCINES AND IMMUNIZATIONS 148585 CENTRAL AMERICA AND THE CARIBBEAN 0 0 PROGRAM SERVICES MATERNAL & CHILD HEALTH 221020 CENTRAL AMERICA AND THE CARIBBEAN 0 0 PROGRAM SERVICES CROSS PROGRAM 7899 CENTRAL AMERICA AND THE CARIBBEAN 0 0 GRANTMAKING 206082 EAST ASIA AND THE PACIFIC 4 61 PROGRAM SERVICES REPRODUCTIVE HEALTH 765912 EAST ASIA AND THE PACIFIC 0 0 PROGRAM SERVICES EMERGING AND EPIDEMIC DISEASES 2491750 EAST ASIA AND THE PACIFIC 0 0 PROGRAM SERVICES VACCINES AND IMMUNIZATIONS 1341745 EAST ASIA AND THE PACIFIC 0 0 PROGRAM SERVICES MATERNAL & CHILD HEALTH 74869 EAST ASIA AND THE PACIFIC 0 0 PROGRAM SERVICES CROSS PROGRAM 16577 EAST ASIA AND THE PACIFIC 0 0 PROGRAM SERVICES HEALTH TECHOLOGIES 967341 EAST ASIA AND THE PACIFIC 0 0 MANAGEMENT & GENERAL MANAGEMENT & GENERAL 24999 EAST ASIA AND THE PACIFIC 0 0 GRANTMAKING 6656790 EUROPE 2 26 MANAGEMENT & GENERAL MANAGEMENT & GENERAL 1053 EUROPE 0 0 PROGRAM SERVICES CROSS PROGRAM 16307 EUROPE 0 0 PROGRAM SERVICES EMERGING AND EPIDEMIC DISEASES 3294076 EUROPE 0 0 PROGRAM SERVICES HEALTH TECHOLOGIES 797781 EUROPE 0 0 PROGRAM SERVICES MATERNAL & CHILD HEALTH 517919 EUROPE 0 0 PROGRAM SERVICES REPRODUCTIVE HEALTH 1588391 EUROPE 0 0 PROGRAM SERVICES VACCINES AND IMMUNIZATIONS 9366544 EUROPE 0 0 GRANTMAKING 10510893 MIDDLE EAST AND NORTH AFRICA 0 0 MANAGEMENT & GENERAL MANAGEMENT & GENERAL 14765 MIDDLE EAST AND NORTH AFRICA 0 0 PROGRAM SERVICES MATERNAL & CHILD HEALTH 38703 MIDDLE EAST AND NORTH AFRICA 0 0 PROGRAM SERVICES VACCINCES AND IMMUNIZATIONS 71114 MIDDLE EAST AND NORTH AFRICA 0 0 PROGRAM SERVICES CROSS PROGRAMS 991 MIDDLE EAST AND NORTH AFRICA 0 0 GRANTMAKING 44603 NORTH AMERICA 0 0 PROGRAM SERVICES EMERGING AND EPIDEMIC DISEASES 230736 NORTH AMERICA 0 0 PROGRAM SERVICES HEALTH TECHOLOGIES 63517 NORTH AMERICA 0 0 PROGRAM SERVICES MATERNAL & CHILD HEALTH 19153 NORTH AMERICA 0 0 PROGRAM SERVICES REPRODUCTIVE HEALTH 14752 NORTH AMERICA 0 0 PROGRAM SERVICES VACCINES AND IMMUNIZATIONS 230057 RUSSIA AND THE NEWLY INDEPENDENT STATES 1 1 MANAGEMENT & GENERAL MANAGEMENT & GENERAL 543 RUSSIA AND THE NEWLY INDEPENDENT STATES 0 0 PROGRAM SERVICES EMERGING AND EPIDEMIC DISEASES 1176357 RUSSIA AND THE NEWLY INDEPENDENT STATES 0 0 PROGRAM SERVICES HEALTH TECHOLOGIES 1780 RUSSIA AND THE NEWLY INDEPENDENT STATES 0 0 PROGRAM SERVICES REPRODUCTIVE HEALTH 2203 RUSSIA AND THE NEWLY INDEPENDENT STATES 0 0 PROGRAM SERVICES VACCINES AND IMMUNIZATIONS 109000 RUSSIA AND THE NEWLY INDEPENDENT STATES 0 0 GRANTMAKING 1223358 SOUTH AMERICA 1 2 MANAGEMENT & GENERAL MANAGEMENT & GENERAL 400 SOUTH AMERICA 0 0 PROGRAM SERVICES EMERGING AND EPIDEMIC DISEASES 23620 SOUTH AMERICA 0 0 PROGRAM SERVICES HEALTH TECHOLOGIES 34239 SOUTH AMERICA 0 0 PROGRAM SERVICES MATERNAL & CHILD HEALTH 151232 SOUTH AMERICA 0 0 PROGRAM SERVICES REPRODUCTIVE HEALTH 123488 SOUTH AMERICA 0 0 PROGRAM SERVICES VACCINES AND IMMUNIZATIONS 1723 SOUTH AMERICA 0 0 PROGRAM SERVICES CROSS PROGRAM 1060 SOUTH AMERICA 0 0 GRANTMAKING 438874 SOUTH ASIA 7 79 MANAGEMENT & GENERAL MANAGEMENT & GENERAL 9954 SOUTH ASIA 0 0 PROGRAM SERVICES EMERGING AND EPIDEMIC DISEASES 1431029 SOUTH ASIA 0 0 PROGRAM SERVICES HEALTH TECHOLOGIES 687814 SOUTH ASIA 0 0 PROGRAM SERVICES MATERNAL & CHILD HEALTH 1443052 SOUTH ASIA 0 0 PROGRAM SERVICES REPRODUCTIVE HEALTH 377511 SOUTH ASIA 0 0 PROGRAM SERVICES VACCINES AND IMMUNIZATIONS 1402695 SOUTH ASIA 0 0 PROGRAM SERVICES CROSS PROGRAM 51585 SOUTH ASIA 0 0 GRANTMAKING 6074647 SUB-SAHARAN AFRICA 24 442 MANAGEMENT & GENERAL MANAGEMENT & GENERAL 121533 SUB-SAHARAN AFRICA 0 0 PROGRAM SERVICES CROSS PROGRAM 134499 SUB-SAHARAN AFRICA 0 0 PROGRAM SERVICES EMERGING AND EPIDEMIC DISEASES 37533156 SUB-SAHARAN AFRICA 0 0 PROGRAM SERVICES HEALTH TECHOLOGIES 2115410 SUB-SAHARAN AFRICA 0 0 PROGRAM SERVICES MATERNAL & CHILD HEALTH 2416866 SUB-SAHARAN AFRICA 0 0 PROGRAM SERVICES REPRODUCTIVE HEALTH 1446221 SUB-SAHARAN AFRICA 0 0 PROGRAM SERVICES VACCINES AND IMMUNIZATIONS 9575120 SUB-SAHARAN AFRICA 0 0 GRANTMAKING 15639078 1 1 39 611 40 612 1257455 122909385 124166840 SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 10370 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 360282 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 10213 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 11429 CHECK/WIRE SOUTH ASIA HEALTH TECHOLOGIES 5718 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 34424 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 47714 CHECK/WIRE SOUTH ASIA VACCINES AND IMMUNIZATIONS 100000 CHECK/WIRE SUB-SAHARAN AFRICA VACCINES AND IMMUNIZATIONS 8735 CHECK/WIRE SUB-SAHARAN AFRICA VACCINES AND IMMUNIZATIONS 34944 CHECK/WIRE EAST ASIA AND THE PACIFIC EMERGING AND EPIDEMIC DISEASES 225565 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 17298 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 15928 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 12593 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 13946 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 19400 CHECK/WIRE SOUTH AMERICA REPRODUCTIVE HEALTH 100541 CHECK/WIRE CENTRAL AMERICA AND THE CARIBBEAN REPRODUCTIVE HEALTH 17960 CHECK/WIRE CENTRAL AMERICA AND THE CARIBBEAN REPRODUCTIVE HEALTH 21708 CHECK/WIRE CENTRAL AMERICA AND THE CARIBBEAN REPRODUCTIVE HEALTH 29610 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 121240 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 112673 CHECK/WIRE EAST ASIA AND THE PACIFIC EMERGING AND EPIDEMIC DISEASES 80036 CHECK/WIRE EAST ASIA AND THE PACIFIC REPRODUCTIVE HEALTH 45286 CHECK/WIRE EAST ASIA AND THE PACIFIC HEALTH TECHOLOGIES 10015 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 16190 CHECK/WIRE EAST ASIA AND THE PACIFIC EMERGING AND EPIDEMIC DISEASES 84538 CHECK/WIRE EUROPE HEALTH TECHOLOGIES 243364 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 19138 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 139087 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 29058 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 10146 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 39386 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 50190 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 11411 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 12699 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 16404 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 5942 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 8014 CHECK/WIRE EAST ASIA AND THE PACIFIC REPRODUCTIVE HEALTH 10940 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 13281 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 8493 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 13118 CHECK/WIRE EAST ASIA AND THE PACIFIC REPRODUCTIVE HEALTH 209285 CHECK/WIRE CENTRAL AMERICA AND THE CARIBBEAN MATERNAL & CHILD HEALTH 10500 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 24409 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 51818 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 29466 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 33446 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 146021 CHECK/WIRE SUB-SAHARAN AFRICA VACCINES AND IMMUNIZATIONS 116774 CHECK/WIRE SUB-SAHARAN AFRICA VACCINES AND IMMUNIZATIONS 25709 CHECK/WIRE SUB-SAHARAN AFRICA VACCINES AND IMMUNIZATIONS 1366141 CHECK/WIRE SUB-SAHARAN AFRICA VACCINES AND IMMUNIZATIONS 100675 CHECK/WIRE EAST ASIA AND THE PACIFIC VACCINES AND IMMUNIZATIONS 250000 CHECK/WIRE EAST ASIA AND THE PACIFIC HEALTH TECHOLOGIES 16059 CHECK/WIRE SOUTH ASIA VACCINES AND IMMUNIZATIONS 64592 CHECK/WIRE SOUTH ASIA VACCINES AND IMMUNIZATIONS 373886 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 15750 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 10677 CHECK/WIRE EAST ASIA AND THE PACIFIC REPRODUCTIVE HEALTH 1738530 CHECK/WIRE EUROPE VACCINES AND IMMUNIZATIONS 550000 CHECK/WIRE EUROPE VACCINES AND IMMUNIZATIONS 369416 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 5420 CHECK/WIRE RUSSIA AND THE NEWLY INDEPENDENT STATES VACCINES AND IMMUNIZATIONS 21566 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 18762 CHECK/WIRE SOUTH ASIA MATERNAL & CHILD HEALTH 8417 CHECK/WIRE EUROPE OVERHEAD 9565 CHECK/WIRE SOUTH AMERICA REPRODUCTIVE HEALTH 6283 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 19388 CHECK/WIRE EUROPE VACCINES AND IMMUNIZATIONS 40092 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 331235 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 38686 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 20111 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 325537 CHECK/WIRE CENTRAL AMERICA AND THE CARIBBEAN REPRODUCTIVE HEALTH 15000 CHECK/WIRE EUROPE VACCINES AND IMMUNIZATIONS 112945 CHECK/WIRE SOUTH AMERICA HEALTH TECHOLOGIES 39177 CHECK/WIRE CENTRAL AMERICA AND THE CARIBBEAN REPRODUCTIVE HEALTH 46000 CHECK/WIRE SOUTH AMERICA MATERNAL & CHILD HEALTH 18629 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 19496 CHECK/WIRE EAST ASIA AND THE PACIFIC REPRODUCTIVE HEALTH 11526 CHECK/WIRE SOUTH ASIA VACCINES AND IMMUNIZATIONS 1127984 CHECK/WIRE SOUTH ASIA VACCINES AND IMMUNIZATIONS 351633 CHECK/WIRE EAST ASIA AND THE PACIFIC HEALTH TECHOLOGIES 17158 CHECK/WIRE EAST ASIA AND THE PACIFIC EMERGING AND EPIDEMIC DISEASES 171027 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 5693 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 17541 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 73000 CHECK/WIRE SOUTH ASIA HEALTH TECHOLOGIES 20000 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 45815 CHECK/WIRE EAST ASIA AND THE PACIFIC VACCINES AND IMMUNIZATIONS 6851 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 17302 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 92189 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 30757 CHECK/WIRE EAST ASIA AND THE PACIFIC HEALTH TECHOLOGIES 11370 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 55125 CHECK/WIRE SOUTH ASIA VACCINES AND IMMUNIZATIONS 356314 CHECK/WIRE SOUTH ASIA VACCINES AND IMMUNIZATIONS 50000 CHECK/WIRE SUB-SAHARAN AFRICA VACCINES AND IMMUNIZATIONS 81287 CHECK/WIRE SUB-SAHARAN AFRICA VACCINES AND IMMUNIZATIONS 2256432 CHECK/WIRE SUB-SAHARAN AFRICA VACCINES AND IMMUNIZATIONS 88090 CHECK/WIRE SUB-SAHARAN AFRICA VACCINES AND IMMUNIZATIONS 22141 CHECK/WIRE EUROPE VACCINES AND IMMUNIZATIONS 271505 CHECK/WIRE EUROPE REPRODUCTIVE HEALTH 7707 CHECK/WIRE SUB-SAHARAN AFRICA VACCINES AND IMMUNIZATIONS 21000 CHECK/WIRE SUB-SAHARAN AFRICA VACCINES AND IMMUNIZATIONS 19305 CHECK/WIRE EUROPE MATERNAL & CHILD HEALTH 225000 CHECK/WIRE EUROPE VACCINES AND IMMUNIZATIONS 318817 CHECK/WIRE EUROPE VACCINES AND IMMUNIZATIONS 251494 CHECK/WIRE EUROPE VACCINES AND IMMUNIZATIONS 119216 CHECK/WIRE EUROPE VACCINES AND IMMUNIZATIONS 28580 CHECK/WIRE SUB-SAHARAN AFRICA VACCINES AND IMMUNIZATIONS 66689 CHECK/WIRE SUB-SAHARAN AFRICA VACCINES AND IMMUNIZATIONS 19972 CHECK/WIRE SUB-SAHARAN AFRICA VACCINES AND IMMUNIZATIONS 26180 CHECK/WIRE SOUTH ASIA REPRODUCTIVE HEALTH 10015 CHECK/WIRE EAST ASIA AND THE PACIFIC VACCINES AND IMMUNIZATIONS 235716 CHECK/WIRE SOUTH AMERICA MATERNAL & CHILD HEALTH 62403 CHECK/WIRE SOUTH AMERICA REPRODUCTIVE HEALTH 114705 CHECK/WIRE SUB-SAHARAN AFRICA VACCINES AND IMMUNIZATIONS 11865 CHECK/WIRE SOUTH ASIA MATERNAL & CHILD HEALTH 63294 CHECK/WIRE SOUTH ASIA VACCINES AND IMMUNIZATIONS 40000 CHECK/WIRE SOUTH ASIA HEALTH TECHOLOGIES 56882 CHECK/WIRE SOUTH ASIA VACCINES AND IMMUNIZATIONS 64976 CHECK/WIRE EAST ASIA AND THE PACIFIC HEALTH TECHOLOGIES 15000 CHECK/WIRE EAST ASIA AND THE PACIFIC HEALTH TECHOLOGIES 10000 CHECK/WIRE CENTRAL AMERICA AND THE CARIBBEAN REPRODUCTIVE HEALTH 10000 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 6250 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 223243 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 20316 CHECK/WIRE SUB-SAHARAN AFRICA HEALTH TECHOLOGIES 12075 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 18705 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 14449 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 14708 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 18222 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 17742 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 10433 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 13851 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 19064 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 17004 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 11991 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 10767 CHECK/WIRE SUB-SAHARAN AFRICA VACCINES AND IMMUNIZATIONS 47864 CHECK/WIRE SUB-SAHARAN AFRICA VACCINES AND IMMUNIZATIONS 83896 CHECK/WIRE SUB-SAHARAN AFRICA VACCINES AND IMMUNIZATIONS 5349 CHECK/WIRE SUB-SAHARAN AFRICA VACCINES AND IMMUNIZATIONS 25000 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 16382 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 34358 CHECK/WIRE SUB-SAHARAN AFRICA VACCINES AND IMMUNIZATIONS 929805 CHECK/WIRE EUROPE HEALTH TECHOLOGIES 50000 CHECK/WIRE EUROPE HEALTH TECHOLOGIES 86000 CHECK/WIRE EAST ASIA AND THE PACIFIC REPRODUCTIVE HEALTH 17177 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 14022 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 18674 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 14576 CHECK/WIRE SUB-SAHARAN AFRICA MATERNAL & CHILD HEALTH 692440 CHECK/WIRE SUB-SAHARAN AFRICA VACCINES AND IMMUNIZATIONS 556198 CHECK/WIRE SUB-SAHARAN AFRICA VACCINES AND IMMUNIZATIONS 18141 CHECK/WIRE SUB-SAHARAN AFRICA VACCINES AND IMMUNIZATIONS 13846 CHECK/WIRE SUB-SAHARAN AFRICA VACCINES AND IMMUNIZATIONS 32344 CHECK/WIRE SUB-SAHARAN AFRICA VACCINES AND IMMUNIZATIONS 16536 CHECK/WIRE SUB-SAHARAN AFRICA VACCINES AND IMMUNIZATIONS 29217 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 13038 CHECK/WIRE SUB-SAHARAN AFRICA VACCINES AND IMMUNIZATIONS 1196184 CHECK/WIRE EAST ASIA AND THE PACIFIC VACCINES AND IMMUNIZATIONS 162497 CHECK/WIRE EUROPE HEALTH TECHOLOGIES 33013 CHECK/WIRE EUROPE VACCINES AND IMMUNIZATIONS 32419 CHECK/WIRE EUROPE VACCINES AND IMMUNIZATIONS 28967 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 14204 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 15026 CHECK/WIRE SUB-SAHARAN AFRICA REPRODUCTIVE HEALTH 25345 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 10667 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 19082 CHECK/WIRE EAST ASIA AND THE PACIFIC HEALTH TECHOLOGIES 15931 CHECK/WIRE SOUTH ASIA REPRODUCTIVE HEALTH 11858 CHECK/WIRE SOUTH ASIA REPRODUCTIVE HEALTH 15000 CHECK/WIRE SUB-SAHARAN AFRICA REPRODUCTIVE HEALTH 15000 CHECK/WIRE SUB-SAHARAN AFRICA REPRODUCTIVE HEALTH 15000 CHECK/WIRE SUB-SAHARAN AFRICA HEALTH TECHOLOGIES 12047 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 19598 CHECK/WIRE SUB-SAHARAN AFRICA VACCINES AND IMMUNIZATIONS 81636 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 130442 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 6912 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 613298 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 11795 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 23336 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 13508 CHECK/WIRE SOUTH ASIA REPRODUCTIVE HEALTH 28174 CHECK/WIRE CENTRAL AMERICA AND THE CARIBBEAN REPRODUCTIVE HEALTH 18060 CHECK/WIRE SOUTH ASIA MATERNAL & CHILD HEALTH 10010 CHECK/WIRE EAST ASIA AND THE PACIFIC EMERGING AND EPIDEMIC DISEASES 101815 CHECK/WIRE EAST ASIA AND THE PACIFIC EMERGING AND EPIDEMIC DISEASES 29747 CHECK/WIRE EAST ASIA AND THE PACIFIC VACCINES AND IMMUNIZATIONS 94020 CHECK/WIRE EAST ASIA AND THE PACIFIC REPRODUCTIVE HEALTH 10358 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 60916 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 33586 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 5411 CHECK/WIRE EAST ASIA AND THE PACIFIC HEALTH TECHOLOGIES 9158 CHECK/WIRE EAST ASIA AND THE PACIFIC HEALTH TECHOLOGIES 9158 CHECK/WIRE SUB-SAHARAN AFRICA VACCINES AND IMMUNIZATIONS 43450 CHECK/WIRE SUB-SAHARAN AFRICA VACCINES AND IMMUNIZATIONS 504534 CHECK/WIRE EUROPE VACCINES AND IMMUNIZATIONS 75275 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 16380 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 8584 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 15837 CHECK/WIRE EAST ASIA AND THE PACIFIC EMERGING AND EPIDEMIC DISEASES 135631 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 10479 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 13209 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 130365 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 105621 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 7165 CHECK/WIRE EAST ASIA AND THE PACIFIC VACCINES AND IMMUNIZATIONS 85449 CHECK/WIRE EUROPE HEALTH TECHOLOGIES 176355 CHECK/WIRE EUROPE HEALTH TECHOLOGIES 24395 CHECK/WIRE EAST ASIA AND THE PACIFIC EMERGING AND EPIDEMIC DISEASES 157096 CHECK/WIRE SUB-SAHARAN AFRICA REPRODUCTIVE HEALTH 50000 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 17460 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 58621 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 229207 CHECK/WIRE EAST ASIA AND THE PACIFIC VACCINES AND IMMUNIZATIONS 1301069 CHECK/WIRE SUB-SAHARAN AFRICA REPRODUCTIVE HEALTH 8750 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 5100 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 128009 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 10215 CHECK/WIRE SUB-SAHARAN AFRICA VACCINES AND IMMUNIZATIONS 59691 CHECK/WIRE SOUTH ASIA VACCINES AND IMMUNIZATIONS 1500000 CHECK/WIRE EUROPE VACCINES AND IMMUNIZATIONS 2748007 CHECK/WIRE RUSSIA AND THE NEWLY INDEPENDENT STATES EMERGING AND EPIDEMIC DISEASES 1181981 CHECK/WIRE SOUTH ASIA MATERNAL & CHILD HEALTH 8345 CHECK/WIRE EAST ASIA AND THE PACIFIC HEALTH TECHOLOGIES 365993 CHECK/WIRE EAST ASIA AND THE PACIFIC HEALTH TECHOLOGIES 85730 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 16495 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 15113 CHECK/WIRE SOUTH ASIA VACCINES AND IMMUNIZATIONS 1800000 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 87053 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 14930 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 8287 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 56850 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 14103 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 83699 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 13296 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 12852 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 20830 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 12901 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 11839 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 103036 CHECK/WIRE EAST ASIA AND THE PACIFIC REPRODUCTIVE HEALTH 5494 CHECK/WIRE MIDDLE EAST AND NORTH AFRICA MATERNAL & CHILD HEALTH 39999 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 19165 CHECK/WIRE RUSSIA AND THE NEWLY INDEPENDENT STATES EMERGING AND EPIDEMIC DISEASES 19810 CHECK/WIRE EAST ASIA AND THE PACIFIC REPRODUCTIVE HEALTH 5499 CHECK/WIRE CENTRAL AMERICA AND THE CARIBBEAN MATERNAL & CHILD HEALTH 6599 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 13745 CHECK/WIRE SUB-SAHARAN AFRICA REPRODUCTIVE HEALTH 15000 CHECK/WIRE SUB-SAHARAN AFRICA REPRODUCTIVE HEALTH 7513 CHECK/WIRE SOUTH AMERICA HEALTH TECHOLOGIES 23959 CHECK/WIRE SOUTH AMERICA HEALTH TECHOLOGIES 31046 CHECK/WIRE SOUTH AMERICA HEALTH TECHOLOGIES 38131 CHECK/WIRE EUROPE VACCINES AND IMMUNIZATIONS 876517 CHECK/WIRE EUROPE VACCINES AND IMMUNIZATIONS 55000 CHECK/WIRE EUROPE VACCINES AND IMMUNIZATIONS 49674 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 508754 CHECK/WIRE SUB-SAHARAN AFRICA HEALTH TECHOLOGIES 80419 CHECK/WIRE SUB-SAHARAN AFRICA HEALTH TECHOLOGIES 19869 CHECK/WIRE EUROPE VACCINES AND IMMUNIZATIONS 40000 CHECK/WIRE SUB-SAHARAN AFRICA REPRODUCTIVE HEALTH 43015 CHECK/WIRE EUROPE VACCINES AND IMMUNIZATIONS 60000 CHECK/WIRE EUROPE VACCINES AND IMMUNIZATIONS 722350 CHECK/WIRE EUROPE VACCINES AND IMMUNIZATIONS 189517 CHECK/WIRE SUB-SAHARAN AFRICA VACCINES AND IMMUNIZATIONS 399143 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 17212 CHECK/WIRE EAST ASIA AND THE PACIFIC HEALTH TECHOLOGIES 50000 CHECK/WIRE EAST ASIA AND THE PACIFIC EMERGING AND EPIDEMIC DISEASES 64088 CHECK/WIRE EAST ASIA AND THE PACIFIC EMERGING AND EPIDEMIC DISEASES 27289 CHECK/WIRE EAST ASIA AND THE PACIFIC EMERGING AND EPIDEMIC DISEASES 26661 CHECK/WIRE EAST ASIA AND THE PACIFIC VACCINES AND IMMUNIZATIONS 11679 CHECK/WIRE EAST ASIA AND THE PACIFIC REPRODUCTIVE HEALTH 5278 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 24349 CHECK/WIRE EAST ASIA AND THE PACIFIC VACCINES AND IMMUNIZATIONS 589920 CHECK/WIRE CENTRAL AMERICA AND THE CARIBBEAN REPRODUCTIVE HEALTH 19545 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 19573 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 18506 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 24551 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 10868 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 25407 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 7674 CHECK/WIRE SUB-SAHARAN AFRICA HEALTH TECHOLOGIES 18946 CHECK/WIRE SUB-SAHARAN AFRICA HEALTH TECHOLOGIES 20000 CHECK/WIRE SUB-SAHARAN AFRICA HEALTH TECHOLOGIES 15000 CHECK/WIRE EAST ASIA AND THE PACIFIC MATERNAL & CHILD HEALTH 126298 CHECK/WIRE EUROPE HEALTH TECHOLOGIES 240116 CHECK/WIRE EUROPE MATERNAL & CHILD HEALTH 38138 CHECK/WIRE EUROPE VACCINES AND IMMUNIZATIONS 55624 CHECK/WIRE EUROPE VACCINES AND IMMUNIZATIONS 700172 CHECK/WIRE EUROPE VACCINES AND IMMUNIZATIONS 1673389 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 222584 CHECK/WIRE SUB-SAHARAN AFRICA EMERGING AND EPIDEMIC DISEASES 47746 CHECK/WIRE 206 42 1 0 0 0 0 0 PROCEDURE FOR MONITORING GRANTS OUTSIDE THE U.S.: SCHEDULE F, PART I, LINE 2: SUBRECIPIENTS MUST SUBMIT PROGRESS REPORTS THAT ARE REVIEWED BY RESPONSIBLE PATH PROGRAM MANAGERS AND PROGRAM ADMINISTRATORS TO ENSURE THAT PROGRAM GOALS ARE ATTAINED IN ACCORDANCE WITH AGREEMENT REQUIREMENTS. THE RESPONSIBLE PROGRAM MANAGERS AND PROGRAM ADMINISTRATORS CONTACT SUBRECIPIENTS WITH QUESTIONS OR FOLLOW UP ON ANY AREA OF CONCERN. IN SOME CASES, SUBAWARD TERMS MAY REQUIRE SPECIFIED DELIVERABLES IN ADDITION TO, OR IN LIEU OF, TECHNICAL REPORTS. IN ADDITION, DISCRETIONARY ON-SITE VISITS ARE CONDUCTED TO EVALUATE BOTH COMPLIANCE WITH THE SCIENTIFIC OBJECTIVES OF THE PROJECT AND THE APPROPRIATENESS OF THE SUBRECIPIENT'S ADMINISTRATIVE SYSTEMS AND PROCESSES. PATH ALSO USES CROSS-PROGRAM INDICATORS TO TRACK OVERALL ORGANIZATIONAL PERFORMANCE AND LINK OUR WORK AND THE WORK OF SUBRECIPIENTS TO SPECIFIC IMPROVEMENTS IN HEALTH-RELATED OUTCOMES. MONITORING THIS SET OF INDICATORS HELPS PATH SET FUTURE BENCHMARKS AND ADOPT BEST PRACTICES THAT IMPROVE PROGRAMMATIC EFFECTIVENESS OVER TIME. 1 AKROS INC - RESEARCH ANALYTICS PO BOX 457 LARAMIE WY 82073 263669995 N/A 667422 EMERGING AND EPIDEMIC DISEASES BROADREACH HEALTHCARE LLC 2500 WILSON BLVD SUITE 220 ARLINGTON VA 222013848 861052728 N/A 1433706 EMERGING AND EPIDEMIC DISEASES ELIZABETH GLASER PEDIATRIC AIDS FOUNDATION 1140 CONNECTICUT AVE NW WASHINGTON DC 20036 954191698 501(C)(3) 3906688 EMERGING AND EPIDEMIC DISEASES ELIZABETH GLASER PEDIATRIC AIDS FOUNDATION 1140 CONNECTICUT AVE NW WASHINGTON DC 20036 954191698 501(C)(3) 530167 EMERGING AND EPIDEMIC DISEASES ELIZABETH GLASER PEDIATRIC AIDS FOUNDATION 1140 CONNECTICUT AVE NW WASHINGTON DC 20036 954191698 501(C)(3) 121719 EMERGING AND EPIDEMIC DISEASES EMORY UNIVERSITY 1599 CLIFTON RD NE 4TH FLOOR MAILSTOP 1499/001/1BH ATLANTA GA 30322 580566256 501(C)(3) 1489482 EMERGING AND EPIDEMIC DISEASES EMPOWERING COMMUNICATIONS 13273 FIJI WAY 210 MARINA DEL REY CA 90292 561843042 N/A 25313 EMERGING AND EPIDEMIC DISEASES FAMILY HEALTH INTERNATIONAL (FHI) CHANCERY BLVD 2ND FLOOR WASHINGTON DC 20036 237413005 501(C)(3) 52685 EMERGING AND EPIDEMIC DISEASES FAMILY HEALTH INTERNATIONAL (FHI) CHANCERY BLVD 2ND FLOOR WASHINGTON DC 20036 237413005 501(C)(3) 10000 EMERGING AND EPIDEMIC DISEASES HEALTH ALLIANCE INTERNATIONAL 4534 11TH AVE NE SEATTLE WA 98105 943047981 501(C)(3) 357084 EMERGING AND EPIDEMIC DISEASES JHPIEGO 1615 THAMES STREET BALTIMORE MD 21231 237424444 N/A 4189462 EMERGING AND EPIDEMIC DISEASES MEDICAL CARE DEVELOPMENT INC (MCD) 8401 COLESVILLE ROAD 425 SILVER SPRING MD 20910 016022787 501(C)(3) 38000 EMERGING AND EPIDEMIC DISEASES PATHFINDER INTERNATIONAL NINE GALEN ST SUITE 217 WATERTOWN MA 02472 530235320 501(C)(3) 484092 EMERGING AND EPIDEMIC DISEASES POPULATION ACTION INTERNATIONAL 1300 19TH ST NW WASHINGTON DC 20036 520812075 501(C)(3) 125000 EMERGING AND EPIDEMIC DISEASES POPULATION COUNCIL CHANCERY BLVD 2ND FLOOR NEW YORK NY 10017 520595110 501(C)(3) 754193 EMERGING AND EPIDEMIC DISEASES SOUTH AFRICA PARTNERS 89 SOUTH STREET SUITE 700 BOSTON MA 021112679 043396641 501(C)(3) 6764 EMERGING AND EPIDEMIC DISEASES THE GLOBAL BUSINESS COALITION ON HIVAIDS TUBERCULOSIS AND MALARIA (GBC) 110 WILLIAM ST SUITE 1800 NEW YORK NY 10038 134185520 501(C)(3) 114015 EMERGING AND EPIDEMIC DISEASES THE POPULATION COUNCIL CHANCERY BLVD 2ND FLOOR NEW YORK NY 10017 912088484 501(C)(3) 942594 EMERGING AND EPIDEMIC DISEASES TULANE UNIVERSITY 1440 CANAL ST NEW ORLEANS LA 70112 720423889 501(C)(3) 331671 EMERGING AND EPIDEMIC DISEASES WOMEN DELIVER 588 BROADWAY SUITE 5033 NEW YORK NY 10012 264462256 N/A 600000 EMERGING AND EPIDEMIC DISEASES WORLD VISION 300 I ST NE WASHINGTON DC 20002 951922279 501(C)(3) 3927245 EMERGING AND EPIDEMIC DISEASES BERKELEY AIR MONITORING GROUP 46 SHATTUCK AVE BERKELEY CA 94704 263881064 N/A 6360 HEALTH TECHOLOGIES BETH ISRAEL DEACONESS MEDICAL CENTER 330 BROOKLINE AVE BOSTON MA 02215 042103881 501(C)(3) 18823 HEALTH TECHOLOGIES CASCADE DESIGNS INC 4000 FIRST AVE S SEATTLE WA 98134 910969695 N/A 6000 HEALTH TECHOLOGIES CASCADE DESIGNS INC 4000 FIRST AVE S SEATTLE WA 98134 910969695 N/A 130457 HEALTH TECHOLOGIES CDC FOUNDATION 55 PARK PLACE SUITE 400 ATLANTA GA 30303 582106707 501(C)(3) 27920 HEALTH TECHOLOGIES CONRAD 1911 N FORT MYER DR SUITE 900 ARLINGTON VA 22209 546055378 501(C)(3) 67030 HEALTH TECHOLOGIES DIGITAL GREEN FOUNDATION 2342 SHATTUCK AVE 151 BERKELEY CA 94704 262418959 501(C)(3) 17391 HEALTH TECHOLOGIES FRED HUTCHINSON CANCER RESEARCH CENTER PO BOX 19024 SEATTLE WA 98109 237156071 501(C)(3) 39763 HEALTH TECHOLOGIES FRED HUTCHINSON CANCER RESEARCH CENTER PO BOX 19024 SEATTLE WA 98109 237156071 501(C)(3) 96207 HEALTH TECHOLOGIES FRED HUTCHINSON CANCER RESEARCH CENTER PO BOX 19024 SEATTLE WA 98109 237156071 501(C)(3) 95993 HEALTH TECHOLOGIES FRED HUTCHINSON CANCER RESEARCH CENTER PO BOX 19024 SEATTLE WA 98109 237156071 501(C)(3) 42835 HEALTH TECHOLOGIES INSTITUTE FOR ONE WORLD HEALTH 280 UTAH AVE SUITE 250 S SAN FRANCISCO CA 94080 943384500 501(C)(3) 254145 HEALTH TECHOLOGIES IQUUM INC 700 NICKERSON RD MARLBOROUGH MA 01752 043471059 N/A 54057 HEALTH TECHOLOGIES MASSACHUSETTS GENERAL HOSPITAL 55 FRUIT STREET BOSTON MA 02114 041564655 501(C)(3) 10000 HEALTH TECHOLOGIES MASSACHUSETTS GENERAL HOSPITAL 55 FRUIT STREET BOSTON MA 02114 041564655 501(C)(3) 10000 HEALTH TECHOLOGIES NORTHWESTERN UNIVERSITY 633 CLARK STREET EVANSTON IL 60208 362167817 501(C)(3) 26148 HEALTH TECHOLOGIES PUBLIC HEALTH INSTITUTE 555 12TH STREET 10TH FLOOR OAKLAND CA 946074046 941646278 501(C)(3) 352519 HEALTH TECHOLOGIES SYMBIENT PRODUCT DEVELOPMENT 1061 LA MIRADA COURT VISTA CA 92081 200857602 N/A 68623 HEALTH TECHOLOGIES UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL 104 AIRPORT DRIVE CB 1350 CHAPEL HILL NC 275991350 566001393 501(C)(3) 38427 HEALTH TECHOLOGIES UNIVERSITY OF PITTSBURGH 204 CRAFT AVE PITTSBURGH PA 15213 250965591 501(C)(3) 21055 HEALTH TECHOLOGIES UNIVERSITY OF WASHINGTON 4333 BROOKLYN AVE NE SEATTLE WA 98195 916001537 501(C)(3) 438461 HEALTH TECHOLOGIES UNIVERSITY OF WASHINGTON 4333 BROOKLYN AVE NE SEATTLE WA 98195 916001537 501(C)(3) 70653 HEALTH TECHOLOGIES UNIVERSITY OF WASHINGTON 4333 BROOKLYN AVE NE SEATTLE WA 98195 916001537 501(C)(3) 38834 HEALTH TECHOLOGIES VILLAGEREACH 601 N 34TH STREET SEATTLE WA 98103 912083484 501(C)(3) 145000 HEALTH TECHOLOGIES VILLAGEREACH 601 N 34TH STREET SEATTLE WA 98103 912083484 501(C)(3) 8985 HEALTH TECHOLOGIES YALE UNIVERSITY 47 COLLEGE SUITE SUITE 216 NEW HAVEN CT 065103209 060646973 501(C)(3) 321030 HEALTH TECHOLOGIES CARE INC 151 ELLIS ST NE ATLANTA GA 300302440 131685039 501(C)(3) 122760 MATERNAL & CHILD HEALTH JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH 615 N WOLFE STREET W1100 BALTIMORE MD 21205 520595110 501(C)(3) 188030 MATERNAL & CHILD HEALTH KANSAS STATE UNIVERSITY 2 FAIRCHILD HALL MANHATTAN KS 665061103 480771751 501(C)(3) 163404 MATERNAL & CHILD HEALTH WORLD VISION INC PO BOX 9716 DEPT W FEDERAL WAY WA 980639716 951922279 501(C)(3) 157124 MATERNAL & CHILD HEALTH FAMILY HEALTH INTERNATIONAL (FHI) CHANCERY BLVD 2ND FLOOR WASHINGTON DC 20036 237413005 501(C)(3) 377035 REPRODUCTIVE HEALTH GEORGETOWN UNIVERSITY INSTITUTE FOR REPRODUCTIVE HEALTH 4301 CONNECTICUT AVE NW SUITE 310 WASHINGTON DC 20008 500196603 501(C)(3) 111998 REPRODUCTIVE HEALTH INTERNATIONAL PLANNED PARENTHOOD FEDERATION (IPPF) 120 WALL ST 9TH FLOOR NEW YORK NY 10005 131845455 N/A 56922 REPRODUCTIVE HEALTH JHPIEGO 1615 THAMES STREET BALTIMORE MD 21231 237424444 N/A 109666 REPRODUCTIVE HEALTH JOHN SNOW INC 1616 N FORT MYER DR 16TH FLOOR ARLINGTON VA 22209 042578580 N/A 18062 REPRODUCTIVE HEALTH POPULATION ACTION INTERNATIONAL 1300 19TH ST NW WASHINGTON DC 20036 520812075 501(C)(3) 17500 REPRODUCTIVE HEALTH POPULATION REFERENCE BUREAU (PRB) 1875 CONNECTICUT AVE NW WASHINGTON DC 20009 530214030 501(C)(3) 24020 REPRODUCTIVE HEALTH POPULATION SERVICES INTERNATIONAL (PSI) 1120 19TH STREET NW SUITE 600 WASHINGTON DC 20036 560942853 501(C)(3) 15000 REPRODUCTIVE HEALTH ALBERT B SABIN VACCINE INSTITUTE 2000 PENNSYLVANIA AVE SUITE 7100 WASHINGTON DC 20006 061389829 501(C)(3) 40000 VACCINES AND IMMUNIZATIONS BIOJECT INC 20245 SW 95TH AVE TUALATIN OR 97062 930881020 N/A 35000 VACCINES AND IMMUNIZATIONS CDC FOUNDATION 55 PARK PLACE SUITE 400 ATLANTA GA 30303 582106707 501(C)(3) 22737 VACCINES AND IMMUNIZATIONS EMORY UNIVERSITY 1599 CLIFTON RD NE 4TH FLOOR MAILSTOP 1499/001/1BH ATLANTA GA 30322 580566256 501(C)(3) 11524 VACCINES AND IMMUNIZATIONS FOOD & DRUG ADMINISTRATION (FDA) 10903 NEW HAMPSHIRE AVE SILVER SPRING MD 20093 530196965 GOVERNMENT 75000 VACCINES AND IMMUNIZATIONS FOOD & DRUG ADMINISTRATION (FDA) 10903 NEW HAMPSHIRE AVE SILVER SPRING MD 20093 530196965 GOVERNMENT 90592 VACCINES AND IMMUNIZATIONS FOOD & DRUG ADMINISTRATION (FDA) 10903 NEW HAMPSHIRE AVE SILVER SPRING MD 20093 530196965 GOVERNMENT 326675 VACCINES AND IMMUNIZATIONS FRED HUTCHINSON CANCER RESEARCH CENTER PO BOX 19024 SEATTLE WA 98109 237156071 501(C)(3) 10205 VACCINES AND IMMUNIZATIONS FRED HUTCHINSON CANCER RESEARCH CENTER PO BOX 19024 SEATTLE WA 98109 237156071 501(C)(3) 15308 VACCINES AND IMMUNIZATIONS FRED HUTCHINSON CANCER RESEARCH CENTER PO BOX 19024 SEATTLE WA 98109 237156071 501(C)(3) 23986 VACCINES AND IMMUNIZATIONS GEORGE WASHINGTON UNIVERSITY 2121 I STREET NW SUITE 601 WASHINGTON DC 20052 530196584 N/A 64350 VACCINES AND IMMUNIZATIONS INOVIO BIOMEDICAL CORPORATION 450 SENTRY PARKWAY BLUE BELL PA 19422 330969592 N/A 497116 VACCINES AND IMMUNIZATIONS JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH 615 N WOLFE STREET W1100 BALTIMORE MD 21205 520595110 501(C)(3) 104325 VACCINES AND IMMUNIZATIONS JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH 615 N WOLFE STREET W1100 BALTIMORE MD 21205 520595110 501(C)(3) 42146 VACCINES AND IMMUNIZATIONS JOHNS HOPKINS UNIVERSITY 615 N WOLFE STREET BALTIMORE MD 21205 131687001 501(C)(3) 17769 VACCINES AND IMMUNIZATIONS NAT INS OF ALLERGY & INFECTIOUS DISEASE (NIAID) 6610 ROCKLEDGE DR SUITE 2800 BETHESDA MD 208926606 520858115 GOVERNMENT 953690 VACCINES AND IMMUNIZATIONS NAT INS OF ALLERGY & INFECTIOUS DISEASE (NIAID) 6610 ROCKLEDGE DR SUITE 2800 BETHESDA MD 208926606 520858115 GOVERNMENT 361228 VACCINES AND IMMUNIZATIONS NAT INS OF ALLERGY & INFECTIOUS DISEASE (NIAID) 6610 ROCKLEDGE DR SUITE 2800 BETHESDA MD 208926606 520858115 GOVERNMENT 109581 VACCINES AND IMMUNIZATIONS NAT INS OF ALLERGY & INFECTIOUS DISEASE (NIAID) 6610 ROCKLEDGE DR SUITE 2800 BETHESDA MD 208926606 520858115 GOVERNMENT 205770 VACCINES AND IMMUNIZATIONS NAT INS OF ALLERGY & INFECTIOUS DISEASE (NIAID) 6610 ROCKLEDGE DR SUITE 2800 BETHESDA MD 208926606 520858115 GOVERNMENT 50754 VACCINES AND IMMUNIZATIONS NAVAL MEDICAL RESEARCH CENTER (NMRC) 503 ROBERT GRANT AVE SILVER SPRING MD 209107500 470100048 GOVERNMENT 79627 VACCINES AND IMMUNIZATIONS NEW YORK UNIVERSITY 650 FIRST AVE NEW YORK NY 10016 135562308 501(C)(3) 59149 VACCINES AND IMMUNIZATIONS PAN AMERICAN HEALTH ORGANIZATION (PAHO) 525 23RD STREET NW WASHINGTON DC 20037 237072046 501(C)(3) 75000 VACCINES AND IMMUNIZATIONS PARALLEL SOLUTIONS INC 767 C CONCORD AVENUE CAMBRIDGE MA 02138 043565762 N/A 15000 VACCINES AND IMMUNIZATIONS PARALLEL SOLUTIONS INC 767 C CONCORD AVENUE CAMBRIDGE MA 02138 043565762 N/A 30000 VACCINES AND IMMUNIZATIONS PROFECTUS BIOSCIENCES INC 6411 BECKLEY STREET BALTIMORE MD 21224 020579416 N/A 191305 VACCINES AND IMMUNIZATIONS SABIN VACCINE INSTITUTE 2000 PENNSYLVANIA AVE SUITE 7100 WASHINGTON DC 20006 061389829 501(C)(3) 10000 VACCINES AND IMMUNIZATIONS SANARIA INC 9800 MEDICAL CENTER DR SUITE A ROCKVILLE MD 20850 562354362 N/A 120000 VACCINES AND IMMUNIZATIONS SEATTLE BIOMEDICAL RESEARCH INSTITUTE 1660 S COLUMBIAN WAY S-151F SEATTLE WA 98108 910961784 501(C)(3) 44123 VACCINES AND IMMUNIZATIONS UNIVERSITY OF KANSAS CENTER FOR RESEARCH INC 2385 IRVING HILL ROAD LAWRENCE KS 66045 480680117 501(C)(3) 82500 VACCINES AND IMMUNIZATIONS UNIVERSITY OF MARYLAND BALTIMORE 620 W LEXINGTON ST BALTIMORE MD 21201 526002033 501(C)(3) 23364 VACCINES AND IMMUNIZATIONS UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL THE 104 AIRPORT DRIVE CB 1350 CHAPEL HILL NC 275991350 566001393 501(C)(3) 8894 VACCINES AND IMMUNIZATIONS UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL THE 104 AIRPORT DRIVE CB 1350 CHAPEL HILL NC 275991350 566001393 501(C)(3) 35574 VACCINES AND IMMUNIZATIONS UNIVERSITY OF WASHINGTON 4333 BROOKLYN AVE NE SEATTLE WA 98195 916001537 501(C)(3) 48053 VACCINES AND IMMUNIZATIONS UNIVERSITY OF WASHINGTON 4333 BROOKLYN AVE NE SEATTLE WA 98195 916001537 501(C)(3) 5996 VACCINES AND IMMUNIZATIONS WALTER REED ARMY INSTITUTE OF RESEARCH (WRAIR) 503 ROBERT GRANT AVE SILVER SPRING MD 109107500 520664528 GOVERNMENT 185141 VACCINES AND IMMUNIZATIONS WALTER REED ARMY INSTITUTE OF RESEARCH (WRAIR) 503 ROBERT GRANT AVE SILVER SPRING MD 109107500 520664528 GOVERNMENT 149865 VACCINES AND IMMUNIZATIONS WALTER REED ARMY INSTITUTE OF RESEARCH (WRAIR) 503 ROBERT GRANT AVE SILVER SPRING MD 109107500 520664528 GOVERNMENT 251872 VACCINES AND IMMUNIZATIONS PATH DRUG SOLUTIONS 2201 WESTLAKE AVE SUITE 200 SEATTLE WA 98121 943384500 501(C)(3) 1231793 EMERGING AND EPIDEMIC DISEASES WALTER REED ARMY INSTITUTE OF RESEARCH (WRAIR) 503 ROBERT GRANT AVE SILVER SPRING MD 109107500 520664528 GOVERNMENT 40314 VACCINES AND IMMUNIZATIONS REPRODUCTIVE HEALTH REPRODUCTIVE HEALTH MANOFF GROUP 4301 CONNECTICUT AVE NW SUITE 310 WASHINGTON DC 20006 043030192 N/A -9241 MATERNAL & CHILD HEALTH SABIN VACCINE INSTITUTE 2000 PENNSYLVANIA AVE SUITE 7100 WASHINGTON DC 20006 061389829 501(C)(3) -19436 VACCINES AND IMMUNIZATIONS 42 20 PROCEDURE FOR MONITORING GRANTS IN THE U.S.: PART I, LINE 2: SCHEDULE I, PART I, LINE 2: SUBRECIPIENTS ARE REQUIRED TO SUBMIT PROGRESS REPORTS, WHICH ARE REVIEWED BY RESPONSIBLE PATH PROGRAM MANAGERS AND PROGRAM ADMINISTRATORS TO ENSURE THAT PROGRAM GOALS ARE ATTAINED IN ACCORDANCE WITH AGREEMENT REQUIREMENTS. THE RESPONSIBLE PROGRAM MANAGERS AND PROGRAM ADMINISTRATORS CONTACT SUBRECIPIENTS WITH QUESTIONS AND FOLLOW UP ON ANY CONCERNS. IN SOME CASES, SUBAWARD TERMS MAY REQUIRE SPECIFIED DELIVERABLES IN ADDITION TO, OR IN LIEU OF, TECHNICAL REPORTS. IN ADDITION, DISCRETIONARY ON-SITE VISITS ARE CONDUCTED TO EVALUATE BOTH COMPLIANCE WITH THE SCIENTIFIC OBJECTIVES OF THE PROJECT AND THE APPROPRIATENESS OF THE SUBRECIPIENT'S ADMINISTRATIVE SYSTEMS AND PROCESSES. PATH ALSO USES CROSS-PROGRAM INDICATORS TO TRACK OVERALL ORGANIZATIONAL PERFORMANCE AND LINK OUR WORK AND THE WORK OF SUBRECIPIENTS TO SPECIFIC IMPROVEMENTS IN HEALTH-RELATED OUTCOMES. MONITORING THIS SET OF INDICATORS HELPS PATH SET FUTURE BENCHMARKS AND ADOPT BEST PRACTICES THAT IMPROVE PROGRAMMATIC EFFECTIVENESS OVER TIME. X X 1 1 X X X X 0 0 0 0 0 0 0 1 0 CHRISTOPHER J ELIAS 100133 0 123321 0 50 0 12016 0 889 0 236409 0 0 0 STEVEN B DAVIS 205500 0 10000 0 100 0 12241 0 7112 0 234953 0 0 0 ERIC G WALKER 240882 0 10000 0 1140 0 26368 0 10635 0 289025 0 0 0 AYORINDE ARNOLD AJAYI 250390 0 10000 0 0 0 29540 0 6256 0 296186 0 0 0 CARLOS CLINTON CAMPBELL 186683 0 0 0 12555 0 19266 0 2531 0 221035 0 0 0 CATHARINE HOWARD TAYLOR 204790 0 0 0 0 0 24491 0 7689 0 236970 0 0 0 DANIEL LASTER 205697 0 10000 0 28 0 23873 0 10584 0 250182 0 0 0 DAVID C KASLOW 232506 0 20000 0 15100 0 18600 0 8359 0 294565 0 0 0 ERIC A ARNOLD 201774 0 0 0 125 0 24112 0 10524 0 236535 0 0 0 JACQUELINE D SHERRIS 250390 0 10000 0 300 0 27617 0 2876 0 291183 0 0 0 JANE E HUTCHINGS 188006 0 0 0 0 0 21905 0 10521 0 220432 0 0 0 JOAN LITTLEFIELD 129918 0 0 0 71858 0 14239 0 8405 0 224420 0 0 0 JOHN W BOSLEGO 315915 0 15000 0 0 0 30000 0 8973 0 369888 0 0 0 JULIE M PULERWITZ 177897 0 0 0 0 0 21260 0 8749 0 207906 0 0 0 KATHLEEN M NEUZIL 221351 0 0 0 225 0 23511 0 9958 0 255045 0 0 0 KATHRYN A O'DRISCOLL 196634 0 0 0 940 0 19122 0 10521 0 227217 0 0 0 MARLOW KEE 200324 0 0 0 3247 0 23370 0 10522 0 237463 0 0 0 MICHAEL J FREE 217699 0 0 0 0 0 26124 0 10327 0 254150 0 0 0 MICHELLE FOLSOM 171441 0 0 0 0 0 20573 0 7531 0 199545 0 0 0 RACHEL WILSON 175471 0 0 0 990 0 21082 0 9345 0 206888 0 0 0 RAMONA ANNE BYRKIT 144426 0 0 0 75297 0 16552 0 8482 0 244757 0 0 0 RIKKA E TRANGSRUD 163768 0 0 0 62899 0 18557 0 9000 0 254224 0 0 0 SARAH C TEMPLE 200255 0 10000 0 840 0 16271 0 7730 0 235096 0 0 0 ASHLEY BIRKETT 232607 0 0 0 159 0 25582 0 10602 0 268950 0 0 0 DUNCAN OWENS EARLE 204802 0 0 0 52527 0 24576 0 8813 0 290718 0 0 0 JEAN A NTUMBA BIDUAYA 79127 0 0 0 160262 0 8309 0 9830 0 257528 0 0 0 JOHN SKIBIAK 176877 0 0 0 167627 0 21177 0 10499 0 376180 0 0 0 TRAD M HATTON 106648 0 0 0 124955 0 12798 0 10005 0 254406 0 0 0 PART I, LINE 1A HOUSING ALLOWANCE & TAX INDEMNIFICATION ARE ONLY PROVIDED TO THOSE INDIVIDUALS WHO ARE EXPATRIATE EMPLOYEES. ALL BENEFIT PAYMENTS ARE MADE ACCORDING TO OUR EXPATRIATE POLICY. PART I, LINE 3: PATH ENGAGES WITH A CONSULTING FIRM TO REVIEW THE COMPENSATION FOR EACH OF THE SENIOR MANAGEMENT POSITION. PATH PROVIDES AN ANNUAL SALARY ADJUSTMENT EACH JANUARY BASED ON THE OVERALL LABOR MARKET MOVEMENT. PART I, LINE 7 BONUS COMPENSATION HAS BEEN REFLECTED IN PART II, COLUMN (B)(II). X 15 197302 FMV X SUPPLIES 1 135 COST OR SALES PRICE 0 0 1 0 METHOD FOR DETERMINING NUMBER OF CONTRIBUTORS: PART I, COLUMN (B): THIS COLUMN REFLECTS THE NUMBER OF CONTRIBUTIONS. FORM 990, PART VI, SECTION B, LINE 11 THE FORM 990 WAS PREPARED BY AN OUTSIDE ACCOUNTING FIRM USING INFORMATION PROVIDED BY PATH ACCOUNTING SERVICES STAFF. PATH SENIOR MANAGEMENT REVIEWED THE DRAFT FORM. A COPY OF THE DRAFT WAS SENT TO THE BOARD OF DIRECTORS FOR COMMENT. AFTER THE COMMENT PERIOD, THE PRESIDENT AND CEO SIGNED THE RETURN AND FILED WITH THE IRS. FORM 990, PART VI, SECTION B, LINE 12C BOARD MEMBERS, PATH MANAGEMENT, AND ALL STAFF ABOVE A DESIGNATED LEVEL IN THE ORGANIZATION MUST COMPLETE A CONFLICT OF INTEREST DISCLOSURE FORM EACH YEAR. ALL FORMS ARE REVIEWED AND KEPT ON FILE. A CONFLICT MANAGEMENT PLAN IS DEVELOPED FOR ANY PERSON WITH A SIGNIFICANT ACTUAL OR PERCEIVED CONFLICT OF INTEREST. FORM 990, PART VI, SECTION B, LINE 15 THE BOARD'S COMPENSATION COMMITTEE ANNUALLY REVIEWS SALARY AND BENEFITS FOR KEY EMPLOYEE POSITIONS. THE COMPENSATION AND BENEFITS FOR PATH'S PRESIDENT AND CEO ARE REVIEWED AND APPROVED BY THE ENTIRE BOARD OF DIRECTORS EACH YEAR AT THE MAY BOARD MEETING. PATH ROUTINELY USES THE SERVICES OF EXTERNAL FIRMS TO ASSESS AND BENCHMARK EXECUTIVE COMPENSATION (PRESIDENT/CEO AND VICE PRESIDENTS). THE LAST MAJOR REVIEW WAS COMPLETED IN 2011, WHEN PATH ENGAGED MERCER (A COMPENSATION, BENEFITS, AND HUMAN RESOURCES CONSULTING FIRM) TO REVIEW CURRENT AND PROPOSED BASE SALARIES OF PATH'S PRESIDENT/CEO, VICE PRESIDENTS, AND PROGRAM/DEPARTMENT LEADERS. MERCER USED DATA FROM MULTIPLE SOURCES TO EVALUATE CURRENT AND PROPOSED BASE SALARIES FOR THESE POSITIONS. THE BOARD'S COMPENSATION COMMITTEE REVIEWED THE MERCER REPORT AND APPROVED THE COMPENSATION PACKAGES FOR THE VICE PRESIDENTS, WITH RATIFICATION BY THE BOARD. THE BOARD ALSO APPROVED THE COMMITTEE'S RECOMMENDATION FOR THE PRESIDENT/CEO'S COMPENSATION. ADDITIONALLY, MERCER REVIEWED THE PROPOSED TOTAL COMPENSATION AND BENEFIT PACKAGE FOR THE PRESIDENT/CEO POSITION AND OBTAINED A SIGNIFICANT NUMBER OF DATA POINTS TO ASCERTAIN ITS REASONABLENESS AND APPROPRIATENESS. THE BOARD REVIEWED MERCER'S FINDINGS AND APPROVED THE TOTAL PACKAGE FOR THIS POSITION. FORM 990, PART VI, SECTION C, LINE 19 PATH MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC UPON REQUEST. PATH VACCINE SOLUTIONS 2201 WESTLAKE AVENUE SEATTLE WA 98109 830431851 ADVANCE DEVELOPMENT OF VACCINES TO IMPROVE THE HEALTH OF CHILDREN WA 501(C)(3) 11A PATH 1 ORGANIZATION FOR APPROPRIATE TECHNOLOGY IN HEALTH 25 BUILDING B0 SHOTA RUSTAVELI STR KYIV UP REDUCE THE HEALTH BURDEN IN UKRAINE UP N/A N/A PATH 1 PATH DRUG SOLUTIONS (FORMERLY INSTITUTE FOR ONEWORLD HEALTH) 280 UTAH AVENUE SUITE 250 SAN FRANCISCO CA 94080 943384500 DEVELOPMENT & DISTRIBUTION OF SAFE, EFFECTIVE, AND AFFORDABLE MEDICINES CA 501(C)(3) 11A PATH 1 FOUNDATION FOR APPROPRIATE TECHNOLOGIES IN HEALTH - SWITZERLAND 207 ROUTE DE FERNEY 1218 LE GRAND-S GENEVA SZ EDUCATIONAL AND SCIENTIFIC PROMOTION OF HEALTH SZ N/A N/A PATH 1 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 PATH VACCINE SOLUTIONS C 12756027 FMV PATH VACCINE SOLUTIONS Q 27450457 FMV PATH VACCINE SOLUTIONS B 82082 FMV ORGANIZATION FOR APPROPRIATE TECHNOLOGY IN HEALTH B 1181981 FMV ORGANIZATION FOR APPROPRIATE TECHNOLOGY IN HEALTH C 117142 FMV ORGANIZATION FOR APPROPRIATE TECHNOLOGY IN HEALTH Q 2735923 FMV PATH DRUG SOLUTIONS B 1231793 FMV PATH DRUG SOLUTIONS C 1360058 FMV PATH DRUG SOLUTIONS Q 10347194 FMV FOUNDATION FOR APPROPRIATE TECHNOLOGIES IN HEALTH - SWITZERLAND B 2748007 FMV FOUNDATION FOR APPROPRIATE TECHNOLOGIES IN HEALTH - SWITZERLAND Q 2752089 FMV